<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03865914</url>
  </required_header>
  <id_info>
    <org_study_id>S2017-133-01</org_study_id>
    <nct_id>NCT03865914</nct_id>
  </id_info>
  <brief_title>Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy</brief_title>
  <official_title>Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Municipal Science &amp; Technology Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospitals affiliated to the China PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the rapid increase of diabetic nephropathy worldwide, type 2 diabetes mellitus(DM) is
      the leading cause of end-stage renal disease(ESRD). Pathological types of diabetic kidney
      disease(DKD) could be mainly divided into diabetic nephropathy（DN）and non-diabetic renal
      diseases（NDRD）. There are no accurate renal biopsy indications and standardized operation
      procedures for type 2 diabetic nephropathy. The clinical stages of type 2 diabetic
      nephropathy still referred to the Mogensen stage of type 1 diabetic nephropathy. Thus, our
      study aim to clarify the differences in clinical phenotype between type 2 DN and type 2 NDRD,
      analysis the correlation between clinical and pathological features, and offer the criteria
      for clinical staging and prognosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change in eGFR and urine protein from baseline</measure>
    <time_frame>24months</time_frame>
    <description>eGFR is calculated using the CKD-EPI formula, involving gender, age, and serum creatinine.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Diabetic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Type 2 diabetic nephropathy</arm_group_label>
    <description>The cohort will be followed for at least two years. The cohort will be divided into 2 groups according the pathological results of patients,and at least 3 groups according to clinical features such as renal function and proteinuria.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, urine, kidney tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The aim of this study is to clarify the differences in clinical phenotype between type 2 DN
        and type 2 NDRD, analysis the correlation between clinical and pathological features, and
        offer the criteria for clinical staging and prognosis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age≥18, male or female

          -  Clinical diagnosed as type 2 diabetes mellitus

          -  The presence of renal impairment including: microalbuminuria or overt proteinuria or
             renal insufficiency

          -  The renal biopsy was performed with complete renal pathological diagnosis

          -  Obtaining the signed informed consent from patients

        Exclusion Criteria:

          -  The history of the disease was not complete

          -  Clinical diagnosed as other secondary renal diseases

          -  Patients with hereditary kidney disease

          -  Autoimmune diseases

          -  Patients with malignant tumor were expected to survive less than 6 months

          -  Pregnancy and lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiangmei Chen, MD.&amp;Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiangmei Chen, MD.&amp;Ph.D</last_name>
    <phone>+86 010 66935462</phone>
    <email>xmchen301@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zheyi Dong, MD.&amp;Ph.D</last_name>
    <phone>+86 010 66935462</phone>
    <email>shengdai26@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiangmei Chen, MD.&amp;Ph.D</last_name>
      <phone>+86 010 66935462</phone>
      <email>xmchen301@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Qian Wang, MM</last_name>
      <phone>+86 010 66935462</phone>
      <email>794317255@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Xiangmei Chen, MD.&amp;Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zheyi Dong, MD.&amp;Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 2, 2019</study_first_submitted>
  <study_first_submitted_qc>March 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2019</study_first_posted>
  <last_update_submitted>March 7, 2019</last_update_submitted>
  <last_update_submitted_qc>March 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Xiangmei Chen</investigator_full_name>
    <investigator_title>Professor,Chief physician,Academician of Chinese Academy of Engineering</investigator_title>
  </responsible_party>
  <keyword>Diabetic kidney disease (DKD)</keyword>
  <keyword>Diabetic nephropathy（DN)</keyword>
  <keyword>non-diabetic renal diseases（ NDRD)</keyword>
  <keyword>Clinical-pathological correlations</keyword>
  <keyword>differential diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Diabetic Nephropathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The test has not been completed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

